Pathological complete response in advanced intrahepatic cholangiocarcinoma was achieved through tri-modal therapy: A case report and review of literature
This case highlights the potential of a tri-modal therapy combining GEMOX-HAIC, lenvatinib, and toripalimab to convert unresectable ICC to a resectable status, thereby potentially improving patient survival by surgical resection. Further clinical trials investigating this regimen are warranted.
Authors
- Tianzhi Zhang
- Yong Fan (ORCID: https://orcid.org/0000-0002-7107-773X)
- Yingzi Huang (ORCID: https://orcid.org/0000-0001-8304-3580)
- You Li (ORCID: https://orcid.org/0000-0003-2245-5084)
- Di Tang (ORCID: https://orcid.org/0000-0001-8793-8090)
- Gang Deng (ORCID: https://orcid.org/0000-0001-8794-2559)
- Yajun Tang (ORCID: https://orcid.org/0000-0002-9745-1056)
- Min Deng (ORCID: https://orcid.org/0000-0002-6775-2210)
- Ju-Ping Xie
Institutions
- Sun Yat-sen University (CN)
- The Seventh Affiliated Hospital of Sun Yat-sen University (CN)
Publication Details
- Journal
- World Journal of Gastrointestinal Oncology
- Published
- 2025-07-12
- DOI
- https://doi.org/10.4251/wjgo.v17.i7.108650
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00